Arkolith/Insider Trading/ANIP/Form 4

Mutz Christopher

HEAD OF RARE DISEASEANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed Feb 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$538K
Net Open-Market Flow
-$538K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2026Tax withholding(F)2K$77.36$186K90K
Feb 12, 2026Sell(S)7K$76.55$538K93K
Feb 12, 2026Tax withholding(F)3K$76.70$243K100K

Transaction Codes

F
Shares withheld for taxes
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001846487-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML